Delivery Order DJBP0109SB110221-15B10920FVB110017

Cytopathology & Thyrosequence Testing Service Option Year 1 was awarded to Cytopath Biopsy Lab Inc. on October 1, 2022 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The firm fixed price delivery order, valued at $35,045, calls for cytopathology and thyrosequence testing services to be provided to the agency through September 30, 2023. Place of performance will be in Northport, New York. No set aside designation was applied to this...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a $400,750 firm fixed price delivery order contract to Cytopath Biopsy Lab Inc. for cytopathology and ThyroSeq testing services. The contract has a period of performance through May 31, 2022 to support the agency's healthcare programs. As the prime contractor, Cytopath Biopsy Lab Inc. will leverage its Cblpath division to provide diagnostic pathology testing at its laboratory in...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $120,000 firm fixed price delivery order contract to Cytopath Biopsy Lab Inc. for ThyroSeq testing services to support cancer screening and diagnosis. As the prime contractor, Cytopath Biopsy Lab Inc. will perform the testing under the brand name Cblpath at their facility located in Gobernador Piñero, Puerto Rico. No set-aside designation was applied to this award to provide these...

This federal contract award from the Department of Veterans Affairs Veterans Health Administration (VA VHA) was issued to Cytopath Biopsy Lab Inc., doing business as Cblpath, a provider of specialized anatomic pathology and molecular diagnostic laboratory services. The $98,250.00 firm fixed price delivery order is for Cytopath Biopsy Lab Inc. to provide cytopathology and ThyroSeq genetic mutation testing services to support cancer screening and diagnosis programs within the VA's Veterans...

Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $12,000 firm fixed price delivery order contract for cytopathology and ThyroSeq testing services. The contract is associated with the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 4 and has a period of performance through May 31, 2023. Under this contract, Cblpath will provide cytopathology laboratory testing and molecular diagnostic testing for thyroid cancer to...

This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...

This $64,400.00 firm fixed price delivery order was awarded to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The order is for cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs. Cblpath is a specialized anatomic pathology and molecular diagnostics laboratory that has previously provided ThyroSequence testing to the VA and Department of Defense...

This federal contract award was issued by the Defense Health Agency (DHA) to Cytopath Biopsy Lab Inc. (doing business as Cblpath), a provider of specialized anatomic pathology and molecular diagnostic laboratory services. The $105,000.00 firm fixed price purchase order is for "THYRO SEQUENCE TESTING" services to support cancer screening and diagnosis programs within the defense health system. Cytopath Biopsy Lab Inc. has previously provided similar ThyroSeq molecular diagnostic testing...

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $151,200.00. The contract is for the provision of ThyroSeq V.2 molecular testing services, which are used for cancer screening and diagnosis. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with a focus on delivering ThyroSeq testing to federal agencies, including the Department...

The Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 awarded a firm-fixed-price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular testing services. The $2,250,000.00 contract has a period of performance from October 13, 2023 to October 12, 2025. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with expertise in cancer screening and...